Quoin Pharmaceuticals (QNRX) Net Shares Issued and Repurchased (2021 - 2026)

Quoin Pharmaceuticals has disclosed Net Shares Issued and Repurchased across 6 years of filings, most recently posting $804661.0 for Q1 2026.

• In Q1 2026, Net Shares Issued and Repurchased changed N/A year-over-year to $804661.0; the TTM figure through Mar 2026 stood at $804661.0 (changed N/A YoY), while the FY2025 annual figure was $171313.0, up 259.94% from the prior year.
• Net Shares Issued and Repurchased came in at $804661.0 for Q1 2026 at Quoin Pharmaceuticals, up from $171313.0 in the prior quarter.
• In the past five years, Net Shares Issued and Repurchased ranged from a high of $9.0 million in Q1 2023 to a low of $47595.0 in Q4 2024.
• Average Net Shares Issued and Repurchased over 5 years is $2.7 million, with a median of $583346.0 recorded in 2023.
• Year-over-year, Net Shares Issued and Repurchased jumped 1427.08% in 2022 and sank 91.84% in 2024.
• Over 5 years, Net Shares Issued and Repurchased stood at $448779.0 in 2022, then grew by 29.99% to $583346.0 in 2023, then slumped by 91.84% to $47595.0 in 2024, then surged by 259.94% to $171313.0 in 2025, then jumped by 369.7% to $804661.0 in 2026.
• Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $804661.0 in Q1 2026, $171313.0 in Q4 2025, and $47595.0 in Q4 2024.